Invention Grant
- Patent Title: Triazolopyridine inhibitors of myeloperoxidase
-
Application No.: US15756367Application Date: 2016-08-30
-
Publication No.: US10407422B2Publication Date: 2019-09-10
- Inventor: Joanne M. Smallheer , Scott A. Shaw , Oz Scott Halpern , Carol Hui Hu , Ellen K. Kick
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Elliot Korsen
- International Application: PCT/US2016/049352 WO 20160830
- International Announcement: WO2017/040449 WO 20170309
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D487/08
Abstract:
The present invention provides compounds of Formula (I): wherein A is as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and/or eosinophil peroxidase (EPX) inhibitors, which may be used as medicaments.
Public/Granted literature
- US20190023701A1 TRIAZOLOPYRIDINE INHIBITORS OF MYELOPEROXIDASE Public/Granted day:2019-01-24
Information query
